Join the club for FREE to access the whole archive and other member benefits.

Use of rilmenidine drug showed lifespan and healthspan benefits in both young and old animals

With a global ageing population, the benefits of delaying ageing, even if slightly, are immense

25-Jan-2023

Key points from article :

Researchers demonstrate that animals treated with rilmenidine have increased lifespan and improved health markers.

Young and older animals treated with rilmenidine, a drug currently used to treat hypertension, showed increased lifespan and improved health markers.

The effects of the drug mimic those of caloric restriction.

A caloric restriction diet has been considered the most robust antiaging intervention, promoting longevity across species. 

The researchers found that rilmenidine extends lifespan in C elegans by approximately 19% and improves healthspan.

They found lifespan and healthspan benefits in both young and old animals.

João Pedro de Magalhães, who led the research, said: “Repurposing drugs capable of extending lifespan and healthspan ... if rilmenidine may have other clinical applications.”

"It would be interesting to test rilmenidine in normal mice for longevity and antiaging effects", he added.

The research was carried out at Harvard Medicine and was published in Aging Cell

Mentioned in this article:

Click on resource name for more details.

Aging Cell

Scientific journal devoted to age related diseases

Harvard Medical School

Graduate medical school of Harvard University

João Pedro de Magalhães

Professor of Molecular Biogerontology at University of Birmingham Institute of Inflammation and Ageing, consultant, futurist, speaker

Topics mentioned on this page:
Life Extension
Use of rilmenidine drug showed lifespan and healthspan benefits in both young and old animals